521 related articles for article (PubMed ID: 23567343)
1. Immune responses to infectious laryngotracheitis virus.
Coppo MJ; Hartley CA; Devlin JM
Dev Comp Immunol; 2013 Nov; 41(3):454-62. PubMed ID: 23567343
[TBL] [Abstract][Full Text] [Related]
2. Development of an enzyme-linked immunosorbent assay to detect chicken serum antibody to glycoprotein G of infectious laryngotracheitis virus.
Shil NK; Markham PF; Noormohammadi AH; O'Rourke D; Devlin JM
Avian Dis; 2012 Sep; 56(3):509-15. PubMed ID: 23050467
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
[TBL] [Abstract][Full Text] [Related]
4. Protection induced by infectious laryngotracheitis virus vaccines alone and combined with Newcastle disease virus and/or infectious bronchitis virus vaccines.
Vagnozzi A; García M; Riblet SM; Zavala G
Avian Dis; 2010 Dec; 54(4):1210-9. PubMed ID: 21313841
[TBL] [Abstract][Full Text] [Related]
5. Long-term protection against a virulent field isolate of infectious laryngotracheitis virus induced by inactivated, recombinant, and modified live virus vaccines in commercial layers.
Palomino-Tapia VA; Zavala G; Cheng S; García M
Avian Pathol; 2019 Jun; 48(3):209-220. PubMed ID: 30640536
[TBL] [Abstract][Full Text] [Related]
6. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the transcriptional status of host cytokines and viral genes in the trachea of vaccinated and non-vaccinated chickens after challenge with the infectious laryngotracheitis virus.
Vagnozzi A; Riblet S; Zavala G; Ecco R; Afonso CL; García M
Avian Pathol; 2016; 45(1):106-13. PubMed ID: 26926298
[TBL] [Abstract][Full Text] [Related]
8. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
[TBL] [Abstract][Full Text] [Related]
9. Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing glycoprotein B of infectious laryngotracheitis virus and chicken IL-18.
Chen HY; Cui P; Cui BA; Li HP; Jiao XQ; Zheng LL; Cheng G; Chao AJ
FEMS Immunol Med Microbiol; 2011 Nov; 63(2):289-95. PubMed ID: 22077232
[TBL] [Abstract][Full Text] [Related]
10. Infectious Laryngotracheitis Virus Viral Chemokine-Binding Protein Glycoprotein G Alters Transcription of Key Inflammatory Mediators
Coppo MJC; Devlin JM; Legione AR; Vaz PK; Lee SW; Quinteros JA; Gilkerson JR; Ficorilli N; Reading PC; Noormohammadi AH; Hartley CA
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070686
[TBL] [Abstract][Full Text] [Related]
11. Current and future vaccines and vaccination strategies against infectious laryngotracheitis (ILT) respiratory disease of poultry.
García M
Vet Microbiol; 2017 Jul; 206():157-162. PubMed ID: 28057380
[TBL] [Abstract][Full Text] [Related]
12. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
Zhao W; Spatz S; Zhang Z; Wen G; Garcia M; Zsak L; Yu Q
J Virol; 2014 Aug; 88(15):8397-406. PubMed ID: 24829337
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic and Transmission Potential of Wildtype and Chicken Embryo Origin (CEO) Vaccine Revertant Infectious Laryngotracheitis Virus.
Perez-Contreras A; Barboza-Solis C; Najimudeen SM; Checkley S; Meer FV; Joseph T; King R; Ravi M; Peters D; Fonseca K; Gagnon CA; Ojkic D; Abdul-Careem MF
Viruses; 2021 Mar; 13(4):. PubMed ID: 33805117
[TBL] [Abstract][Full Text] [Related]
14. Immune Responses in the Eye-Associated Lymphoid Tissues of Chickens after Ocular Inoculation with Vaccine and Virulent Strains of the Respiratory Infectious Laryngotracheitis Virus (ILTV).
Beltrán G; Hurley DJ; Gogal RM; Sharif S; Read LR; Williams SM; Jerry CF; Maekawa DA; García M
Viruses; 2019 Jul; 11(7):. PubMed ID: 31295877
[TBL] [Abstract][Full Text] [Related]
15. Safety and vaccine efficacy of a glycoprotein G deficient strain of infectious laryngotracheitis virus delivered in ovo.
Legione AR; Coppo MJ; Lee SW; Noormohammadi AH; Hartley CA; Browning GF; Gilkerson JR; O'Rourke D; Devlin JM
Vaccine; 2012 Nov; 30(50):7193-8. PubMed ID: 23084851
[TBL] [Abstract][Full Text] [Related]
16. Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Quinteros JA; Diaz-Méndez A; Thilakarathne D; Fakhri O; Vaz PK; Devlin JM
Vaccine; 2018 Sep; 36(38):5709-5716. PubMed ID: 30104116
[TBL] [Abstract][Full Text] [Related]
17. Replication of recombinant herpesvirus of turkey expressing genes of infectious laryngotracheitis virus in specific pathogen free and broiler chickens following in ovo and subcutaneous vaccination.
Gimeno IM; Cortes AL; Guy JS; Turpin E; Williams C
Avian Pathol; 2011 Aug; 40(4):395-403. PubMed ID: 21812719
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
Wei X; Shao Y; Han Z; Sun J; Liu S
Vet Microbiol; 2020 Nov; 250():108835. PubMed ID: 33011664
[TBL] [Abstract][Full Text] [Related]
19. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
[TBL] [Abstract][Full Text] [Related]
20. Protection against infectious laryngotracheitis by in ovo vaccination with commercially available viral vector recombinant vaccines.
Johnson DI; Vagnozzi A; Dorea F; Riblet SM; Mundt A; Zavala G; García M
Avian Dis; 2010 Dec; 54(4):1251-9. PubMed ID: 21313847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
